Hepagene Therapeutics, Inc., a clinical stage drug discovery and development company, is dedicated to discovering, developing and delivering innovative medicines that help patients prevail over liver disease and other life-threatening diseases. The Company is currently concentrating its efforts on development of treatments for metabolic dysfunction-associated steatohepatitis (MASH).